TABLE 1.
Clinical characteristics and laboratory parameters of elderly subjects (n = 59)
| Variable | Elderly Subjects |
| Age (years) | 86 ± 5 |
| Male gender, n (%) | 14 (24) |
| BMI (kg/m2) | 25.9 ± 4.5 |
| Systolic blood pressure (mmHg) | 142 ± 18 |
| Diastolic blood pressure (mmHg) | 75 ± 11 |
| Current smoking, n (%) | 1 (1.6) |
| Physically active according to WHO, n (%) | 18 (30) |
| Hypertension, n (%) | 42 (70) |
| Type 2 diabetes, n (%) | 16 (27) |
| Lipid lowering treatment, n (%) | 17 (29) |
| Coronary calcium score, Agatston | 99 (0−3856) |
| Subjects with CAC = 0, n (%) | 19 (32.2) |
| Positive remodeling plaques, n (%) | 23 (39) |
| Hypodense plaques, n (%) | 29 (49) |
| Spotty calcified plaques, n (%) | 26 (44) |
| Napkin-ring sign | 10 (17) |
| FMD (%) | 3.60 (1.07−7.40) |
| mean IMT (mm) | 0.86 ± 0.16 |
| TC (mg/dl) | 192 ± 43 |
| VLDL-C (mg/dl) | 29 ± 13 |
| LDL-C (mg/dl) | 108 ± 38 |
| ApoB (mg/dl) | 81 ± 24 |
| HDL-C (mg/dl) | 54 ± 17 |
| ApoA-I (mg/dl) | 147 ± 25 |
| TG (mg/dl) | 131 ± 66 |
| CRP (mg/L) | 2.37 ± 1.78 |
| Fibrinogen (mg/dl) | 357 ± 63 |
| Glucose (mg/dl) | 103 ± 34 |
| Uric acid (mg/dl) | 5.25 ± 1.56 |
| Creatinine (mg/dl) | 0.95 ± 0.28 |
Normally distributed data are presented as mean ± SD and nonnormally distributed data are presented in the form of median (interquartile range). FMD, flow-mediated dilation; IMT, intima-media thickness; WHO, World Health Organization.